- Home
- THRD vs ELLO Comparison
THRD vs ELLO Comparison
Compare THRD & ELLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- THRD
- ELLO
- Stock Information
- Founded
- THRD 2019
- ELLO 1987
- Country
- THRD United States
- ELLO Israel
- Employees
- THRD N/A
- ELLO N/A
- Industry
- THRD Biotechnology: Pharmaceutical Preparations
- ELLO Electric Utilities: Central
- Sector
- THRD Health Care
- ELLO Utilities
- Exchange
- THRD Nasdaq
- ELLO Nasdaq
- Market Cap
- THRD 232.4M
- ELLO 208.2M
- IPO Year
- THRD 2022
- ELLO 1995
- Fundamental
- Price
- THRD $5.25
- ELLO $15.49
- Analyst Decision
- THRD Hold
- ELLO
- Analyst Count
- THRD 3
- ELLO 0
- Target Price
- THRD $5.00
- ELLO N/A
- AVG Volume (30 Days)
- THRD 296.2K
- ELLO 3.5K
- Earning Date
- THRD 05-08-2025
- ELLO 06-30-2025
- Dividend Yield
- THRD N/A
- ELLO N/A
- EPS Growth
- THRD N/A
- ELLO N/A
- EPS
- THRD N/A
- ELLO N/A
- Revenue
- THRD N/A
- ELLO $41,895,641.00
- Revenue This Year
- THRD N/A
- ELLO N/A
- Revenue Next Year
- THRD N/A
- ELLO N/A
- P/E Ratio
- THRD N/A
- ELLO N/A
- Revenue Growth
- THRD N/A
- ELLO N/A
- 52 Week Low
- THRD $3.18
- ELLO $11.08
- 52 Week High
- THRD $16.02
- ELLO $20.81
- Technical
- Relative Strength Index (RSI)
- THRD 75.64
- ELLO 55.11
- Support Level
- THRD $5.16
- ELLO $14.29
- Resistance Level
- THRD $5.22
- ELLO $15.34
- Average True Range (ATR)
- THRD 0.04
- ELLO 0.64
- MACD
- THRD -0.03
- ELLO -0.05
- Stochastic Oscillator
- THRD 100.00
- ELLO 56.11
About THRD Third Harmonic Bio Inc.
Third Harmonic Bio Inc is a biopharmaceutical company focused on the development of the next wave of medicine for the treatment of inflammatory diseases, including dermal, respiratory, and gastrointestinal diseases. The company's product candidate, THB001, is a selective, oral small-molecule inhibitor of KIT, a cell surface receptor that serves as the master regulator of mast cell function and survival. Its other product candidate THB335, is a potent, selective, oral small molecule KIT inhibitor, for the treatment of multiple mast cell-driven inflammatory diseases of the skin, airway, and gastrointestinal tract.
About ELLO Ellomay Capital Ltd (Israel)
Ellomay Capital Ltd is focused on the utility sector. It is an Israeli public company, which focuses its business in the energy and infrastructure sectors. The company's operating segment includes Photovoltaic power plants (PV Plants); Dorad Energy Ltd. (Dorad); Groen Gas Goor B.V. and a Pumped storage hydro power plant (Manara). It generates maximum revenue from the Dorad segment. Geographically, it derives a majority of its revenue from Spain.